Takara Bio Inc.
4974.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥99,704,065 | ¥116,320,890 | ¥208,679,195 | ¥269,850,015 |
| - Cash | ¥29,549,000 | ¥33,171,000 | ¥49,058,000 | ¥22,161,000 |
| + Debt | ¥1,101,000 | ¥968,000 | ¥972,000 | ¥1,047,000 |
| Enterprise Value | ¥71,256,065 | ¥84,117,890 | ¥160,593,195 | ¥248,736,015 |
| Revenue | ¥45,039,000 | ¥43,505,000 | ¥78,142,000 | ¥67,699,000 |
| % Growth | 3.5% | -44.3% | 15.4% | – |
| Gross Profit | ¥26,067,000 | ¥26,908,000 | ¥44,765,000 | ¥49,211,000 |
| % Margin | 57.9% | 61.9% | 57.3% | 72.7% |
| EBITDA | ¥6,502,000 | ¥7,899,000 | ¥25,983,000 | ¥31,704,000 |
| % Margin | 14.4% | 18.2% | 33.3% | 46.8% |
| Net Income | ¥1,042,000 | ¥1,480,000 | ¥16,012,000 | ¥19,849,000 |
| % Margin | 2.3% | 3.4% | 20.5% | 29.3% |
| EPS Diluted | 8.65 | 12.29 | 132.97 | 164.84 |
| % Growth | -29.6% | -90.8% | -19.3% | – |
| Operating Cash Flow | ¥5,844,000 | ¥1,711,000 | ¥36,897,000 | ¥6,985,000 |
| Capital Expenditures | -¥9,871,000 | -¥12,778,000 | -¥5,882,000 | -¥12,539,000 |
| Free Cash Flow | -¥4,027,000 | -¥11,067,000 | ¥31,015,000 | -¥5,554,000 |